JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
-0.76%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$37.2M
AUM Growth
+$37.2M
(-68%)
Cap. Flow
-$78.3M
Cap. Flow
% of AUM
-210.66%
Top 10 Holdings %
Top 10 Hldgs %
54.32%
Holding
45
New
15
Increased
3
Reduced
11
Closed
13
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$1.96M |
| 2 |
CVS Health
CVS
|
$1.76M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.23M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$1.19M |
| 5 |
Eli Lilly
LLY
|
$1.04M |
Top Sells
| 1 |
Moody's
MCO
|
$13.4M |
| 2 |
VF Corp
VFC
|
$11.6M |
| 3 |
Carter's
CRI
|
$11.1M |
| 4 |
YPF
YPF
|
$7.86M |
| 5 |
AGN
Allergan plc
AGN
|
$7.03M |
Sector Composition
| 1 | Healthcare | 51.52% |
| 2 | Consumer Discretionary | 13.96% |
| 3 | Financials | 13.72% |
| 4 | Consumer Staples | 10.18% |
| 5 | Communication Services | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$2.58T
| $2.59M | 1.08% |
3,473
-1,772
| -34% | -$1.32M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $2.39M | 1% |
8,917
-26,217
| -75% | -$7.03M |
|
3
Kraft Heinz
KHC
$33.1B
| $2.2M | 0.92% |
27,997
-14,033
| -33% | -$1.1M |
|
4
Biogen
BIIB
$19.4B
| $2.09M | 0.88% |
8,036
-22,938
| -74% | -$5.97M |
|
5
Gilead Sciences
GILD
$140B
| $2.08M | 0.87% |
22,675
-61,109
| -73% | -$5.61M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $1.96M | 0.82% |
+19,597
| New | +$1.96M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.78M | 0.75% |
12,815
+8,813
| +220% | +$1.23M |
|
|
8
CVS Health
CVS
$92.8B
| $1.76M | 0.74% |
+16,951
| New | +$1.76M |
|
|
AET
9
DELISTED
Aetna Inc
AET
| $1.74M | 0.73% |
15,526
+3,480
| +29% | +$391K |
|
10
AB InBev
BUD
$122B
| $1.58M | 0.66% |
12,700
| – | – |
|
11
Home Depot
HD
$405B
| $1.46M | 0.61% |
10,928
-7,998
| -42% | -$1.07M |
|
12
Apple
AAPL
$3.45T
| $1.35M | 0.57% |
12,419
-6,646
| -35% | -$725K |
|
|
13
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.19M | 0.5% |
+8,418
| New | +$1.19M |
|
14
Booking.com
BKNG
$181B
| $1.11M | 0.47% |
864
-826
| -49% | -$1.07M |
|
|
15
Moody's
MCO
$91.4B
| $1.09M | 0.46% |
11,286
-138,897
| -92% | -$13.4M |
|
16
Visa
V
$683B
| $1.07M | 0.45% |
13,992
-12,824
| -48% | -$981K |
|
|
17
Carter's
CRI
$1.04B
| $1.06M | 0.45% |
10,095
-105,224
| -91% | -$11.1M |
|
|
18
Eli Lilly
LLY
$657B
| $1.04M | 0.44% |
+14,458
| New | +$1.04M |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $926K | 0.39% |
+10,993
| New | +$926K |
|
20
Thermo Fisher Scientific
TMO
$186B
| $925K | 0.39% |
+6,534
| New | +$925K |
|
21
Amgen
AMGN
$155B
| $842K | 0.35% |
+5,619
| New | +$842K |
|
22
AbbVie
ABBV
$372B
| $797K | 0.33% |
+13,950
| New | +$797K |
|
23
Bristol-Myers Squibb
BMY
$96B
| $662K | 0.28% |
+10,366
| New | +$662K |
|
24
Restaurant Brands International
QSR
$20.8B
| $628K | 0.26% |
16,182
+5,032
| +45% | +$195K |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $615K | 0.26% |
+7,457
| New | +$615K |
|